Strides Pharma Science Limited (STAR) — Board Meeting | 31 July 2026

31 July 2026 · NSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Board approved Q3 FY2026 consolidated results with dividend proposal

🔮 What's Next

None

💡 Investor Takeaway

The company proposed a dividend of Rs. 5 per share pending shareholder approval, signaling confidence in cash flow despite revenue decline.

The Board approved unaudited consolidated results for Q3 FY2026 (ended June 30, 2026), showing revenue of ₹12,702.97 crores and profit after tax of ₹1,654.93 crores, down from prior quarter's ₹13,315.98 crores revenue and ₹1,292.81 crores profit. A Limited Review by B S R & Co. LLP found no material misstatements across 36 entities, though 25 subsidiaries and 3 associates were excluded. The filing also disclosed a proposed Rs. 5 per share dividend, a $42.07 million gain from the Pivot Path demerger, and Rs. 174.62 million in product recall provisions.

📄 View Original Announcement (PDF)

📊 Stock Analysis — STAR ✨ Ask AI About This

About Strides Pharma Science Limited (STAR)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹10,612.31 CrP/E: 17.3ROE: 19.7%ROCE: 19.2%Div Yield: 0.43%

View full STAR stock details →

📡 Get AI alerts when STAR files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track STAR — Free

💡 Ask AI about this filing

"How does the proposed dividend compare to FY2025 payout ratio?""What is the expected impact of the Pivot Path stake reduction on future earnings?""When will the full audited results for Q3 FY2026 be released?"

Ask AI Free →

📊 More STAR filings

Announcement — 24 September 2026Strides Pharma Science Limited has announced that its trading window will close on October 1, 2026, ...
🟡 Sustainability Report — 23 September 2026Strides Pharma Science Limited released its FY26 Sustainability Report, detailing ESG performance ac...
🔴 Announcement — 11 September 2026Strides Pharma Science announced that the USFDA completed a cGMP inspection at its Alathur formulati...
Announcement — 19 August 2026Strides Pharma Science announced that its Bengaluru flagship manufacturing facility received a USFDA...
🟡 Board Meeting — 18 August 2026Strides Pharma Science Limited held its 35th Annual General Meeting on August 14, 2026 via video con...

See all STAR filings →

🔥 Also filed on 31 July 2026

KUANTUMKuantum Papers LimitedAnnouncement INDIAGLYCOIndia Glycols LimitedCorporate Action TVVISIONTV Vision LimitedAnnouncement MARUTIMaruti Suzuki India LimitedFinancial Results MARUTIMaruti Suzuki India LimitedFinancial Results RAMRATRam Ratna Wires LimitedFinancial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when STAR files new disclosures

Track STAR filings, board meetings, and corporate actions. Free email alerts at 5 PM.